Summary
This narrative review examines the evidence base and emerging trends in probiotic research, considering their role in restoring and modulating the gut microbiota to support human health. The authors situate probiotics within a broader ecosystem of microbiome-modulating interventions—including prebiotics, symbiotics, postbiotics, and live biotherapeutic products—and identify new research directions driven by advances in microbiome science. The review acknowledges both established associations (gastrointestinal and metabolic health) and emerging applications, whilst noting the field's expansion into novel probiotic variants and genetically modified organisms.
Regional applicability
The review is not geographically specific and addresses global trends in probiotic research and fermented food consumption. Findings on probiotic mechanisms and disease associations are likely transferable to United Kingdom populations; however, regulatory frameworks governing probiotic labelling and health claims differ between jurisdictions, and UK practitioners should refer to Food Standards Agency and MHRA guidance on authorised health claims for probiotic products.
Key measures
Mechanistic pathways of probiotic action; disease associations (irritable bowel syndrome, lactose intolerance, gastroenteritis, obesity, allergies, dermatitis, colic, cardiovascular disease, respiratory infection); probiotic types and dosing approaches.
Outcomes reported
The paper reviews evidence on probiotic mechanisms of action and their associations with prevention or management of gastrointestinal, metabolic, allergic, and infectious diseases in children and adults. It surveys emerging probiotic variants including prebiotics, symbiotics, postbiotics, and live biotherapeutic products as microbiome-modulating interventions.
Topic tags
Dig deeper with Pulse AI.
Ask about this record, its theme or its relevance to UK farming and policy. Pulse AI uses selected catalogue evidence and cites the sources it draws on.